Chris

Marx

Biography

My previous research experience was as a pharmaceutical R&D chemist focused on creating novel biodegradable implants for long-term drug delivery. The work was a joint effort between two startups: Geasa Biosciences and pH Science Holdings Inc. and was funded by grants from the Gates Foundation and FHI360 targeting third-world applications. The work focused on developing a biodegradable female hormonal contraceptive implant 'Casea S' for 18-month contraception while also having a minimal sub-effective release phase 'tail'. Casea S is currently undergoing phase-I human clinical trials (clinical trial ID: NCT05174884). We were also tasked with developing novel HIV-PrEP biodegradable implants.

Upon completion of the grants I decided to pursue my PhD in Materials Science in the Som Lab (SAIL). My focus will be on developing bone cement materials capable of local drug delivery of immunnoadjuvants for tumor treatments.

education

B.S. Chemistry (ACS-Certified), University of Washington - 2015

patents and publications

Baillie, J.H., Baillie, R., Blouin, G., Farahani, N. and Marx, C. (2018). Bioerodible contraceptive implant and methods of use thereof. (U.S. Patent 9,980,850 B2).

Baillie, J.H., Baillie, R., Blouin, G., Farahani, N. and Marx, C. (2019). Bioerodible implant for long-term drug delivery and associated methods of manufacture and use. (U.S. Patent 10,188,602 B2).